Evidence map›Paper›PMID 42773171›Full record

ArticleNature communications2026

Mesoscale proximity labeling at chromatin leads to identification of small molecule mechanism of action.

Cameron J Douglas, Preston Samowitz, Feifei Tong, Alice Long, Caitlin M Bradley, Laszlo Radnai, David W C MacMillan, Courtney A Miller, Gavin Rumbaugh, Ciaran P Seath

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cameron J Douglas *Wertheim UF Scripps, Jupiter, FL, USA.ORCID http://orcid.org/0000-0003-2334-1652
Preston Samowitz *Wertheim UF Scripps, Jupiter, FL, USA.ORCID http://orcid.org/0000-0002-3940-303X
Feifei TongWertheim UF Scripps, Jupiter, FL, USA.
Alice LongMerck Center for Catalysis, Department of Chemistry, Princeton University, Princeton, NJ, USA.
Caitlin M BradleyWertheim UF Scripps, Jupiter, FL, USA.
Laszlo RadnaiWertheim UF Scripps, Jupiter, FL, USA.ORCID http://orcid.org/0000-0001-6843-3740
David W C MacMillanMerck Center for Catalysis, Department of Chemistry, Princeton University, Princeton, NJ, USA.ORCID http://orcid.org/0000-0001-6447-0587
Courtney A MillerWertheim UF Scripps, Jupiter, FL, USA.
Gavin RumbaughWertheim UF Scripps, Jupiter, FL, USA. gavinrumbaugh@ufl.edu.ORCID http://orcid.org/0000-0001-6360-3894
Ciaran P SeathWertheim UF Scripps, Jupiter, FL, USA. cseath@cornell.edu.ORCID http://orcid.org/0000-0002-6774-128X

Funding

Photoredox Catalysis Applications in Organometallics and Chemical BiologyR35GM134897 · NIGMS · PRINCETON UNIVERSITY · PI David W MacMillan · 2020 to 2026
$6.3M
Preclinical development of a precision therapy for a monogenic mental health disorderU01MH136567 · NIMH · UNIVERSITY OF FLORIDA · PI Theodore M Kamenecka, Courtney A Miller · 2024 to 2026
$5.1M
Integrated Platform for Discovery and Validation of Probes that Restore Protein Expression in Single-Gene Causes of Autism and Related DisordersR01MH113648 · NIMH · UNIVERSITY OF FLORIDA · PI MILLER, COURTNEY A, RUMBAUGH, GAVIN R · 2017 to 2023
$4.9M
Photoproximity labeling as a tool for epigenetic drug discoveryR35GM150765 · NIGMS · UNIVERSITY OF FLORIDA · PI Ciaran Seath · 2023 to 2026
$1.9M
NIGMS NIH HHS R35 GM134897NIGMS NIH HHS R35 GM150765NIMH NIH HHS R01 MH113648NIMH NIH HHS U01 MH136567U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM134897U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM150765U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH113648U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) U01MH136567
6 · The paper itself

Abstract

Proximity labeling typically identifies interactomes of single protein or RNA baits, limiting its use for mechanisms distributed across molecular systems. Here, we establish MesoMap, a chromatin-focused mesoscale proximity-labeling strategy that installs nanoscale photocatalysts on multiple histone baits to monitor drug-induced redistribution of proteins near chromatin. MesoMap captured HDAC inhibitor-induced remodeling of chromatin-associated proteins and, in a proof-of-concept de-orphaning application, prioritized a chromatin-proximal CLK/splicing axis for SR-1815, a phenotypically discovered SynGAP-restoring small molecule. Integration with kinase assays, splicing analysis, inhibitor comparisons, and published neuronal validation supports a model in which SR-1815 regulates SynGAP abundance through polypharmacological kinase modulation, including CLK-dependent effects on splicing. Together, these studies establish MesoMap as a complementary approach for resolving drug-induced protein redistribution near chromatin and accelerating mechanism-of-action studies for phenotypic chemical probes.

Indexed as

ChromatinStaining and LabelingAnimalsHistone Deacetylase InhibitorsHistonesHumansProtein Serine-Threonine KinasesProtein-Tyrosine KinasesRNA SplicingChromatinClk dual-specificity kinasesHistone Deacetylase InhibitorsHistonesProtein Serine-Threonine KinasesProtein-Tyrosine Kinases

Identifiers

PMID42773171
PMCPMC13598159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.